Andrew Huberman· PhD
That said, the data on these compounds for PTSD, depression, even eating disorders, are really interesting.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
That said, the data on these compounds for PTSD, depression, even eating disorders, are really interesting.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
And we're probably, again, a few years away from both MDMA, probably a year or two, after that psilocybin, and being treated for PTSD and depression respectively. You know, we have to wait for the Phase 3 studies, but if the results hold up...
You know, that's where I think the psilocybin story for depression and the MDMA story for PTSD seemed more interesting to me.
I think the the data on um psilocybin for depression, uh MDMA, not recreationally but therapeutically for PTSD, I gain for PTSD and for alcohol and other uh substance abuse disorders is very intriguing and I'm not trying to hedge here and play, you know, but I think it's very interesting.
So, you know, you mentioned um uh in severe intractable depression and there are I think really good data there. There's also good data for alcoholism.